Altimmune Stock Story
| ALT Stock | USD 7.04 0.48 6.38% |
Slightly above 54% of Altimmune's investor base is interested to short. The analysis of the overall investor sentiment regarding Altimmune suggests that many traders are impartial. Altimmune's investor sentiment overview provides quick insight into current market opportunities from investing in Altimmune. The current market sentiment, together with Altimmune's historical and current headlines, can help investors time the market. In addition, many technical investors use Altimmune stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Altimmune stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Altimmune daily returns and investor perception about the current price of Altimmune as well as its diversification or hedging effects on your existing portfolios.
Altimmune |
Requested story not found. it has been either deleted or moved. View all stories for Altimmune.
Altimmune Latest Timeline
Altimmune is traded for 7.04. About 62.0% of the company shares are held by institutions such as insurance companies. The book value of Altimmune was presently reported as 2.75. The company recorded a loss per share of 1.66. Altimmune last dividend was issued on the 20th of January 2017. The entity had 1:30 split on the 14th of September 2018.Check out Altimmune Hype Analysis, Altimmune Correlation and Altimmune Performance. For more information on how to buy Altimmune Stock please use our How to Invest in Altimmune guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Complementary Tools for Altimmune Stock analysis
When running Altimmune's price analysis, check to measure Altimmune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Altimmune is operating at the current time. Most of Altimmune's value examination focuses on studying past and present price action to predict the probability of Altimmune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Altimmune's price. Additionally, you may evaluate how the addition of Altimmune to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
Is Altimmune's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Altimmune. If investors know Altimmune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Altimmune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.66) | Revenue Per Share 0.008 | Quarterly Revenue Growth 180 | Return On Assets (0.25) | Return On Equity (0.47) |
The market value of Altimmune is measured differently than its book value, which is the value of Altimmune that is recorded on the company's balance sheet. Investors also form their own opinion of Altimmune's value that differs from its market value or its book value, called intrinsic value, which is Altimmune's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Altimmune's market value can be influenced by many factors that don't directly affect Altimmune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Altimmune's value and its price as these two are different measures arrived at by different means. Investors typically determine if Altimmune is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Altimmune's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.